P55.0
Rh isoimmunization of newborn
Clinical Classification Guidelines
Medical Intelligence & Overview
Rh isoimmunization of a newborn, also known as Hemolytic Disease of the Newborn, occurs when there is an incompatibility between the Rh blood group status of the mother and her baby. This condition can lead to the destruction of the baby's red blood cells, resulting in anemia and other health issues. It is a significant concern in pregnancies where the mother is Rh-negative, and the baby is Rh-positive, highlighting the importance of prenatal screening and management.
Causes & Symptoms
Clinical Causes: Maternal Rh-negative blood type Fetal Rh-positive blood type Rh factor incompatibility during pregnancy, especially after sensitizing events such as miscarriage, abortion, or delivery Failure to receive Rh immunoglobulin prophylaxis during pregnancy or after exposure to fetal blood
Key Symptoms: Jaundice (yellowing of the skin and eyes) in the newborn Swelling or edema, especially involving the face and limbs Enlarged liver and spleen Dark urine due to high bilirubin levels Severe anemia causing pallor and lethargy Poor feeding or irritability In severe cases, signs of heart failure
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of maternal and fetal blood tests and clinical examinations, including:
Treatment Protocols: Managing Rh isoimmunization involves several approaches aimed at reducing hemolysis and managing symptoms:
Clinical Advice & FAQs
Billing Guidance
Is P55.0 a billable ICD-10 code?
Yes, P55.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P55.0?
Clinical documentation must specify the nature of Rh isoimmunization of newborn and any associated comorbidities for accurate reporting.
Cite this Clinical Reference